Product Information
ENOXAPARIN 300 MG/3 ML VIAL is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $9.8758 per ML under NDC 00955101601. Its NADAC has been published 458 times since Dec 18, 2013.
The High Outlier badge above means this manufacturer's average price in the enoxaparin sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/3mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00955101601
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA020164On Market Since
10/3/2011
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 300 MG/3 ML VIAL has been published 458 times since Dec 18, 2013, and over the history we have for it it has declined 80.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.8758 per ML |
|---|---|
| All-time high | $68.5340 (Feb 11, 2015) |
| All-time low | $9.8758 (Jun 17, 2026) |
| 52-week high | $11.6405 |
| 52-week low | $9.8758 |
| Median price | $15.7340 |
| Average price | $24.6550 |
| Largest weekly change | -45.9% (Aug 23, 2017) |
| Weeks tracked | 458 |
| Tracking since | Dec 18, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ENOXAPARIN 300 MG/3 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 300 MG/3 ML VIAL, manufactured by Sanofi-Aventis U.S. LLC, is $9.8758 per ML (NDC 00955101601), effective Jun 24, 2026.
How has the price of ENOXAPARIN 300 MG/3 ML VIAL changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has declined 80.5%. It has been tracked across 458 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 300 MG/3 ML VIAL?
Since Dec 18, 2013, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has ranged from a low of $9.8758 (Jun 17, 2026) to a high of $68.5340 (Feb 11, 2015), with a median of $15.7340 per ML.
Are there cheaper alternatives to ENOXAPARIN 300 MG/3 ML VIAL?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ENOXAPARIN 300 MG/3 ML VIAL, but none are currently priced below it.
Who manufactures ENOXAPARIN 300 MG/3 ML VIAL?
ENOXAPARIN 300 MG/3 ML VIAL (NDC 00955101601) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification